Showing results (2071-2080 of 2,308) with videos related to

Sort By:
Pageof 231
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 20, 2004
Material-specific recognition memory deficits elicited by unilateral hippocampal electrical stimulationSteven G Coleshill, Colin D Binnie, Robin G Morris, et al.
Clinical Breast Cancer|January 5, 2016
Biomarkers That Predict Sensitivity to Heat Shock Protein 90 InhibitorsKomal Jhaveri, Sarat Chandarlapaty, Neil Iyengar, et al.
The Pharmacogenomics Journal|December 24, 2009
Effect of dopamine D3 receptor gene polymorphisms and clozapine treatment response: exploratory analysis of nine polymorphisms and meta-analysis of the Ser9Gly variantR Hwang, C Zai, A Tiwari, et al.
Comparative Medicine|July 2, 2020
Mite Burden and Immunophenotypic Response to Demodex musculi in Swiss Webster, BALB/c, C57BL/6, and NSG MiceMariya G Morris, Rodolfo J Ricart Arbona, Kathleen Daniels, et al.
International Journal of Radiation Oncology, Biology, Physics|December 3, 2014
Rectal toxicity after proton therapy for prostate cancer: an analysis of outcomes of prospective studies conducted at the university of Florida Proton Therapy InstituteRovel J Colaco, Bradford S Hoppe, Stella Flampouri, et al.
Nuclear Medicine Communications|October 9, 2013
Pilot study of 68Ga-DOTA-F(ab')2-trastuzumab in patients with breast cancerVolkan Beylergil, Patrick G Morris, Peter M Smith-Jones, et al.
Acta Oncologica (Stockholm, Sweden)|December 15, 2017
Outcomes following proton therapy for pediatric ependymomaDaniel J Indelicato, Julie A Bradley, Ronny L Rotondo, et al.
Neuroimage|January 30, 2017
A new generation of magnetoencephalography: Room temperature measurements using optically-pumped magnetometersElena Boto, Sofie S Meyer, Vishal Shah, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 17, 2011
A phase I study of dasatinib and weekly paclitaxel for metastatic breast cancerM N Fornier, P G Morris, A Abbruzzi, et al.
International Journal of Radiation Oncology, Biology, Physics|March 20, 2022
Chemoradiation with Hypofractionated Proton Therapy in Stage II-III Non-Small Cell Lung Cancer: A Proton Collaborative Group Phase 2 TrialBradford S Hoppe, Romaine C Nichols, Stella Flampouri, et al.
Pageof 231